Glioblastoma vaccines: past, present, and opportunities

Targeting immunogenic cell death for glioma immunotherapy

Therapeutic cell-based vaccines for glioblastoma multiforme

Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients

Clinical Applications of Immunotherapy for Recurrent Glioblastoma in Adults

Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?

Recent oncolytic virotherapy clinical trials outline a roadmap for the treatment of high-grade glioma

Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines

Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C

The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma